Two different oncofetal fibronectins (FN) have been reported: one, generated by 0-glycosylation in the splicing region lllCS that is recognized by monoclonal antibody (MAb) FDC-6, and another, recognized by MAb BC-I, generated by the alternative splicing of the FN pre-mRNA which includes an extra ty
Distribution of fibronectin isoforms in human renal disease
β Scribed by Anita I. Van Vliet; Hans J. Baelde; Louis-Jean Vleming; Emile de Heer; Jan Anthonie Bruijn
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 294 KB
- Volume
- 193
- Category
- Article
- ISSN
- 0022-3417
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The distribution of fibronectin in tissues of four human foetuses (7β14 gestation weeks/GW) and twenty seven pig foetuses (25β114 days of gestation) was investigated using immunofluorescence and avidin/biotin methods. Fibronectin was abundant in the circulatory and gastrointestinal syst
In a preliminary study, we demonstrated a strong association between the concentration of the glycoprotein fibronectin (FN) in human bile fluid and the presence of malignant biliary diseases. We now present the results of measurements of total FN (tFN) and cellular FN (cFN) within a larger group of
Heterogeneity and tissue specificity of tropomyosin isoforms included in various muscles of the spiny lobster, Panulirus japonicus, were investigated using two-dimensional ureashift gel electrophoresis, two-dimensional gel electrophoresis with first dimension isoelectric focusing and second dimensio
## Abstract The pharmacokinetics of netilmicin in plasma and blister fluid were compared in 10 healthy volunteers with normal renal function and 10 voluntary patients with varying degrees of renal impairment. Netilmicin kinetics in plasma were characterized by an open twoβcompartment kinetic model.
Cellular fibronectins containing the extracellular domain A or B (EDA and EDB) are particularly abundant in fetal and neoplastic tissues. The presence of EDA and EDB was investigated in 28 cases of papillary carcinoma of the thyroid using IST-9 and BC-1 monoclonal antibodies. Immunostaining for EDA